Evidence supports use of on-demand PrEP for HIV prevention
- PMID: 35772418
- DOI: 10.1016/S2352-3018(22)00158-8
Evidence supports use of on-demand PrEP for HIV prevention
Conflict of interest statement
We declare no competing interests. EPFC is supported by a National Health and Medical Research Council (NHMRC) Emerging Leadership Investigator Grant (GNT1172873). CKF is supported by a NHMRC Leadership Investigator Grant (GNT1172900).
Comment on
-
Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study.Lancet HIV. 2022 Aug;9(8):e554-e562. doi: 10.1016/S2352-3018(22)00133-3. Epub 2022 Jun 27. Lancet HIV. 2022. PMID: 35772417
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
